Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Treatment of PAF With the Synaptic System [NA]

View source ↗

Summary

Clinical trial update indicating the Synaptic System trial for paroxysmal atrial fibrillation is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synaptic System

Snippet

Sponsor: Synaptic Medical Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING